loading

Finanzdaten der Tyra Biosciences Inc-Aktie (TYRA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
1.25%
31.45
31.85 29.74 28.60 23.53
Operating Income/Loss
1.25%
-31.45
-31.85 -29.74 -28.60 -23.53
Nonoperating Income/Loss
9.42%
3.354
3.703 4.173 4.588 4.83
Income/Loss From Continuing Operations Before Tax
0.17%
-28.10
-28.15 -25.57 -24.02 -18.70
Income/Loss From Continuing Operations After Tax
0.17%
-28.10
-28.15 -25.57 -24.02 -18.70
Net Income/Loss
0.17%
-28.10
-28.15 -25.57 -24.02 -18.70
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.36%
59.55
59.34 0.6187 58.87 58.67
Diluted Average Shares
0.36%
59.55
59.34 0.6187 58.87 58.67
Basic Earnings Per Share
0.00%
-0.47
-0.47 -0.43 -0.41 -0.32
Diluted Earnings Per Share
0.00%
-0.47
-0.47 -0.43 -0.41 -0.32
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$39.39
price up icon 1.18%
$30.76
price up icon 1.00%
$105.61
price up icon 3.47%
$97.44
price up icon 2.07%
biotechnology ONC
$327.83
price down icon 6.02%
$204.47
price up icon 2.93%
Kapitalisierung:     |  Volumen (24h):